non responder to glp 1 Distribution of responders and non-responders for several key features New *promising* study for GLP1

Given a reduction in both GPx3 and a likely reduction of glutathione production, as has been theorized by others in the field of konzo 13 , the role of oxidative damage and mitigation as a contributing factor of disease susceptibility or severity is only further bolstered by the findings of this study

***** Pseudoephedrine: Prohibited when its concentration in urine is greater than 150 micrograms per millilitre

Protecting samples from unnecessary light exposure and limiting prolonged exposure to air helps preserve consistency

The program provides access to GLP-1 treatments, including oral medications and injections